188 related articles for article (PubMed ID: 19437356)
1. Angiogenesis and pituitary tumors.
Cohen AB; Lessell S
Semin Ophthalmol; 2009; 24(3):185-9. PubMed ID: 19437356
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis in pituitary adenomas.
Yamada S; Takada K
Microsc Res Tech; 2003 Feb; 60(2):236-43. PubMed ID: 12539178
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
[TBL] [Abstract][Full Text] [Related]
4. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
Korsisaari N; Ross J; Wu X; Kowanetz M; Pal N; Hall L; Eastham-Anderson J; Forrest WF; Van Bruggen N; Peale FV; Ferrara N
Clin Cancer Res; 2008 Jan; 14(1):249-58. PubMed ID: 18172277
[TBL] [Abstract][Full Text] [Related]
5. The Edpm5 locus prevents the 'angiogenic switch' in an estrogen-induced rat pituitary tumor.
Pandey J; Bannout A; Wendell DL
Carcinogenesis; 2004 Oct; 25(10):1829-38. PubMed ID: 15166088
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in normal and neoplastic pituitary tissues.
Lloyd RV; Vidal S; Horvath E; Kovacs K; Scheithauer B
Microsc Res Tech; 2003 Feb; 60(2):244-50. PubMed ID: 12539179
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic correlates of giant pituitary adenomas.
Chacko G; Chacko AG; Lombardero M; Mani S; Seshadri MS; Kovacs K; Scheithauer BW
J Clin Neurosci; 2009 May; 16(5):660-5. PubMed ID: 19285407
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between tumor blood vessels heterogeneity and hormonal profile of pituitary adenomas: evidence and controversies.
Bălinişteanu B; Cimpean AM; Melnic E; Coculescu M; Ceauşu RA; Raica M
Anticancer Res; 2014 Oct; 34(10):5413-20. PubMed ID: 25275036
[TBL] [Abstract][Full Text] [Related]
9. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
10. Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour.
Turner HE; Nagy Z; Gatter KC; Esiri MM; Wass JA; Harris AL
Br J Cancer; 2000 Apr; 82(8):1441-5. PubMed ID: 10780524
[TBL] [Abstract][Full Text] [Related]
11. PTTG overexpression is correlated with angiogenesis in human pituitary adenomas.
Minematsu T; Suzuki M; Sanno N; Takekoshi S; Teramoto A; Osamura RY
Endocr Pathol; 2006; 17(2):143-53. PubMed ID: 17159247
[TBL] [Abstract][Full Text] [Related]
12. Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas.
Viacava P; Gasperi M; Acerbi G; Manetti L; Cecconi E; Bonadio AG; Naccarato AG; Acerbi F; Parenti G; Lupi I; Genovesi M; Martino E
J Endocrinol Invest; 2003 Jan; 26(1):23-8. PubMed ID: 12602530
[TBL] [Abstract][Full Text] [Related]
13. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in pituitary adenomas and the normal pituitary gland.
Turner HE; Nagy Z; Gatter KC; Esiri MM; Harris AL; Wass JA
J Clin Endocrinol Metab; 2000 Mar; 85(3):1159-62. PubMed ID: 10720055
[TBL] [Abstract][Full Text] [Related]
15. Role of matrix metalloproteinase 9 in pituitary tumor behavior.
Turner HE; Nagy Z; Esiri MM; Harris AL; Wass JA
J Clin Endocrinol Metab; 2000 Aug; 85(8):2931-5. PubMed ID: 10946906
[TBL] [Abstract][Full Text] [Related]
16. Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas.
Takada K; Yamada S; Teramoto A
Endocr Pathol; 2004; 15(2):131-9. PubMed ID: 15299199
[TBL] [Abstract][Full Text] [Related]
17. Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro.
Ławnicka H; Pisarek H; Kunert-Radek J; Pawlikowski M
Neuro Endocrinol Lett; 2008 Feb; 29(1):113-6. PubMed ID: 18283262
[TBL] [Abstract][Full Text] [Related]
18. Indices of apoptosis and proliferation as potential prognostic markers in non-functioning pituitary adenomas.
Ibrahim AE; Pickering RM; Gawne-Cain ML; King S; Lees PD; Ellison DW
Clin Neuropathol; 2004; 23(1):8-15. PubMed ID: 14986928
[TBL] [Abstract][Full Text] [Related]
19. Microvessel density in pituitary adenomas and carcinomas.
Vidal S; Kovacs K; Horvath E; Scheithauer BW; Kuroki T; Lloyd RV
Virchows Arch; 2001 Jun; 438(6):595-602. PubMed ID: 11469692
[TBL] [Abstract][Full Text] [Related]
20. Neuronal differentiation and expression of neural epitopes in pituitary adenomas.
Johnson MD; Fan X; Bourne P; Walters D
J Histochem Cytochem; 2007 Dec; 55(12):1265-71. PubMed ID: 17875653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
